{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:12:23Z","timestamp":1740028343478,"version":"3.37.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1124\/mol.117.110668","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T15:45:19Z","timestamp":1516376719000},"page":"216-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibitory Effects of Endogenous Linoleic Acid and Glutaric Acid on the Renal Glucuronidation of Berberrubine in Mice and on Recombinant Human UGT1A7, 1A8, and 1A9"],"prefix":"10.1016","volume":"93","author":[{"given":"Na","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiye","family":"Aa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.117.110668_bib1","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1021\/ac051211v","article-title":"Extraction and GC\/MS analysis of the human blood plasma metabolome","volume":"77","author":"Aa","year":"2005","journal-title":"Anal Chem"},{"key":"10.1124\/mol.117.110668_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bcp.2008.06.011","article-title":"In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat","volume":"76","author":"Antonilli","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.117.110668_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mpaic.2012.04.005","article-title":"Renal blood flow, glomerular filtration and plasma clearance","volume":"13","author":"Atherton","year":"2012","journal-title":"Anaesth Intensive Care Med"},{"key":"10.1124\/mol.117.110668_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/bj3150171","article-title":"Evidence for an UDP-glucuronic acid\/phenol glucuronide antiport in rat liver microsomal vesicles","volume":"315","author":"B\u00e1nhegyi","year":"1996","journal-title":"Biochem J"},{"key":"10.1124\/mol.117.110668_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.106.012070","article-title":"Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice","volume":"35","author":"Buckley","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/dmd.108.024190","volume":"37","author":"Buckley","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1440-1746.1996.tb00095.x","article-title":"Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis","volume":"11","author":"Chen","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/mol.117.110668_bib9","doi-asserted-by":"crossref","unstructured":"Court MH, Zhang X, Ding X, Yee KK, Hesse LM, Finel M (2012) Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 42:266\u2013277.","DOI":"10.3109\/00498254.2011.618954"},{"key":"10.1124\/mol.117.110668_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003088-199936060-00005","article-title":"Glucuronidation in humans. Pharmacogenetic and developmental aspects","volume":"36","author":"de Wildt","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.117.110668_bib11","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1194\/jlr.M040519","article-title":"A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders","volume":"54","author":"Fang","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.117.110668_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bph.12932","article-title":"Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease","volume":"172","author":"Feere","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.117.110668_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.toxlet.2012.07.014","article-title":"Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes","volume":"213","author":"Gradinaru","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1124\/mol.117.110668_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-08-447359","article-title":"Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia","volume":"121","author":"Gruber","year":"2013","journal-title":"Blood"},{"key":"10.1124\/mol.117.110668_bib15","doi-asserted-by":"crossref","unstructured":"Gu S, Cao B, Sun R, Tang Y, Paletta JL, Wu X, Liu L, Zha W, Zhao C, Li Y et al. (2015) A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine [published correction in Mol Biosyst (2015) 11:664]. Mol Biosyst 11:463\u2013474.","DOI":"10.1039\/C4MB00500G"},{"key":"10.1124\/mol.117.110668_bib16","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1208\/aapsj080112","article-title":"Cytochrome P450s and other enzymes in drug metabolism and toxicity","volume":"8","author":"Guengerich","year":"2006","journal-title":"AAPS J"},{"key":"10.1124\/mol.117.110668_bib17","doi-asserted-by":"crossref","first-page":"37919","DOI":"10.1038\/srep37919","article-title":"Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/mol.117.110668_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0731-7085(00)00491-X","article-title":"Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection","volume":"25","author":"Hanioka","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/mol.117.110668_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ac201704a","article-title":"Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry","volume":"84","author":"Harbourt","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/mol.117.110668_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/FTD.0b013e3180686146","article-title":"Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients","volume":"29","author":"Inoue","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1124\/mol.117.110668_bib21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.metabol.2010.01.012","article-title":"Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5\u2032-diphosphoglucuronic acid level","volume":"59","author":"Kang","year":"2010","journal-title":"Metabolism"},{"key":"10.1124\/mol.117.110668_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bcp.2008.04.014","article-title":"In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway","volume":"76","author":"Kerdpin","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.117.110668_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.117.110668_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042873","article-title":"UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population","volume":"7","author":"Kua","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/mol.117.110668_bib25","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1016\/j.bmc.2010.06.106","article-title":"Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine","volume":"18","author":"Li","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/mol.117.110668_bib26","article-title":"UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/mol.117.110668_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394C(T) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/mol.117.110668_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0031-6997(24)01351-6","article-title":"Renal drug metabolism","volume":"50","author":"Lohr","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.117.110668_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.117.110668_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1515\/CCLM.2000.026","article-title":"Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA","volume":"38","author":"Mannhalter","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1124\/mol.117.110668_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1124\/dmd.114.062877","article-title":"Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues","volume":"43","author":"Margaillan","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200053586064","article-title":"Polymorphism of UDP-glucuronosyltransferase and drug metabolism","volume":"6","author":"Maruo","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.117.110668_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00204-014-1286-7","article-title":"In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes","volume":"89","author":"Maul","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1124\/mol.117.110668_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jchromb.2008.06.020","article-title":"Determination of mycophenolic acid glucuronide in microsomal incubations using high performance liquid chromatography-tandem mass spectrometry","volume":"870","author":"Mohamed","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/mol.117.110668_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbadis.2012.09.006","article-title":"Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration","volume":"1832","author":"Mutsaers","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.117.110668_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2014.12.001","article-title":"A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development","volume":"30","author":"Oda","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.117.110668_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/mol.117.110668_bib39","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ptr.5395","article-title":"Inhibition of UDP-Glucuronosyltransferases (UGTs) activity by constituents of Schisandra chinensis","volume":"29","author":"Song","year":"2015","journal-title":"Phytother Res"},{"key":"10.1124\/mol.117.110668_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0165-6147(90)90008-V","article-title":"UDP-glucuronosyltransferases: a family of detoxifying enzymes","volume":"11","author":"Tephly","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.117.110668_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2003.08.025","article-title":"Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7","volume":"67","author":"Tsoutsikos","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.117.110668_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.117.110668_bib43","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/FPC.0b013e328256b1b6","article-title":"Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates","volume":"17","author":"Udomuksorn","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.117.110668_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ejca.2010.11.030","article-title":"Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study","volume":"47","author":"van der Bol","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1124\/mol.117.110668_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/dmd.114.061622","article-title":"Mechanism-based inhibitory and peroxisome proliferator-activated receptor \u03b1-dependent modulating effects of silybin on principal hepatic drug-metabolizing enzymes","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1124\/dmd.30.11.1266","article-title":"Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2133\/dmpk.DMPK-13-RG-020","article-title":"Dysregulations of intestinal and colonic UDP-glucuronosyltransferases in rats with type 2 diabetes","volume":"28","author":"Xie","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.117.110668_bib48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/dmd.111.039925","article-title":"UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis","volume":"40","author":"Xu","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib49","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0090-9556(24)13678-1","article-title":"Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats","volume":"28","author":"Yamamura","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/aps.2016.120","article-title":"In vitro assessment of the glucose-lowering effects of berberrubine-9-O-\u03b2-d-glucuronide, an active metabolite of berberrubine","volume":"38","author":"Yang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/mol.117.110668_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine","volume":"121","author":"Yang","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1124\/mol.117.110668_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.etap.2016.08.003","article-title":"High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile","volume":"46","author":"Yang","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1124\/mol.117.110668_bib53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/dmd.105.006601","article-title":"Effect of chronic renal insufficiency on hepatic and renal udp-glucuronyltransferases in rats","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.117.110668_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2013.09.024","article-title":"Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver","volume":"721","author":"Zhang","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.117.110668_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2133\/dmpk.DMPK-12-RG-097","article-title":"Disturbance of hepatic and intestinal UDP-glucuronosyltransferase in rats with trinitrobenzene sulfonic acid-induced colitis","volume":"28","author":"Zhou","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.117.110668_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fitote.2013.11.010","article-title":"Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells","volume":"92","author":"Zhou","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1124\/mol.117.110668_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bcpt.12618","article-title":"Human UDP-glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are inhibited by diethylstilbestrol","volume":"119","author":"Zhu","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2400720X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2400720X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.117.110668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:23:20Z","timestamp":1739960600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2400720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0026895X2400720X"],"URL":"https:\/\/doi.org\/10.1124\/mol.117.110668","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory Effects of Endogenous Linoleic Acid and Glutaric Acid on the Renal Glucuronidation of Berberrubine in Mice and on Recombinant Human UGT1A7, 1A8, and 1A9","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.117.110668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}